Dihydropyridine Calcium Channel Blocker [EPC]

260447 reported adverse events

Drugs of this class: NIFEDIPINE FELODIPINE NIMODIPINE ISRADIPINE NISOLDIPINE AMLODIPINE AND VALSARTAN AMLODIPINE CLEVIDIPINE CLEVIPIDINE FELODIPINE EXTENDED-RELEASE TABLETS OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLET 40/10/25 MG

These side effects are most commonly reported by patients taking drugs of the Dihydropyridine Calcium Channel Blocker [EPC] class:

# Side effect Count
0 FATIGUE 14982
1 DYSPNOEA 14161
2 DIARRHOEA 13706
3 NAUSEA 13452
4 DRUG INEFFECTIVE 12216
5 DIZZINESS 11167
6 HEADACHE 10353
7 OFF LABEL USE 9569
8 PAIN 9398
9 ACUTE KIDNEY INJURY 8948
See all common reactions for Dihydropyridine Calcium Channel Blocker [EPC]

Drugs of the Dihydropyridine Calcium Channel Blocker [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOSPASM 258 0.6701
1 IMMUNISATION 173 0.5786
2 PALMOPLANTAR KERATODERMA 253 0.4884
3 NON-CARDIOGENIC PULMONARY OEDEMA 237 0.3395
4 GINGIVAL HYPERTROPHY 336 0.3134
5 HYPERPARATHYROIDISM SECONDARY 663 0.2847
6 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 284 0.2823
7 DISTRIBUTIVE SHOCK 267 0.2822
8 VASOPLEGIA SYNDROME 288 0.2756
9 NEPHROGENIC ANAEMIA 1184 0.2697
See all enriched reactions for Dihydropyridine Calcium Channel Blocker [EPC]